Cause of Death in Patients With Well-Differentiated Thyroid Carcinoma
β Scribed by Nigel J. P. Beasley; Paul G. Walfish; Ian Witterick; Jeremy L. Freeman
- Book ID
- 110082694
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 52 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa
## Abstract Differentiated thyroid carcinoma (DTC) is associated with prolonged natural history, and even recurrent tumor is not necessarily followed by increased mortality. Prognostic factors and different treatment strategies, therefore, are difficult to assess. One hundred and fiftyβseven patien
## Abstract ## BACKGROUND The followβup of patients with differentiated thyroid carcinoma (DTC) is traditionally carried out with ^131^I whole body scan (^131^I WBS) and serum thyroglobulin (Tg) measurement. Neck ultrasonography (US) is also used. ## METHODS We compared the roles of Tg measureme